Creo Medical Seeks To Make Flexible Electrosurg Tech Attainable For The 'Regular' Endoscopist
Executive Summary
Surgical endoscopy specialist Creo Medical is picking up the pace with its surgeon training program to increase awareness of its CROMA advanced electrosurgical platform within the clinical community. The training – aimed at the majority of "regular endoscopists" – is an integral part of Creo's commercial roll-out plan for the first device to emerge from the platform, which is targeting the gastroenterology field.
You may also be interested in...
Creo Gets Early FDA Green Light For Endoscopy Device
Surgical endoscopy specialist Creo Medical has received the nod of approval to start selling its Speedboat RS2 device and CROMA platform in the US. The FDA cleared the use of the surgical endoscopy device ahead of schedule, processing the company's 510(k) application just 49 days from submission.
Creo Medical Braves Public Market To Score $25m IPO
Surgical endoscopy specialist Creo Medical Group plc has met its IPO target and raised £20m ($25m) ahead of its listing on the London Stock Exchange's Alternative Investment Market (AIM) on Friday 9 December.
Qiagen’s Ambitions: Standing Alone And Strengthening Infectious Disease Portfolio
Qiagen official Antoine Marchal outlines how NeuModx will strengthen its position in the infectious disease space.